3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Mycosis Fungoides
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Hairy Cell
3
Leukemia
3
Hodgkin Disease
3
Head and Neck Neoplasms
3
Brain Neoplasms
3
Blast Crisis
3
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Cisplatin
4
angiotensin I (1-7)
3
Radiotherapy
3
Radiation
3
Injections
3
Water
2
RRx-001
2
Interleukin 1 Receptor Antagonist Protein
2
Drug Therapy
2
Amifostine
2
tempol
1
peppermint oil
1
pegfilgrastim
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
glucarpidase
1
fish oil triglycerides
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Xylitol
1
Vaccinium myrtillus extract
1
Tramadol
1
Therapeutics
1
Surgical Procedures, Operative
1
Sorbic Acid
1
Sodium Bicarbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mucositis
×
Therapeutics
×
Clear all
NCT04046250
2023-08-25
TK112690
Tosk, Inc.
Phase 2
Completed
22 enrolled
10 charts